Iovance Biotherapeutics stock soaring 74% this year

Statements (3)

1. ▲ Bullish

   Iovance Biotherapeutics shares rose 256 percent in the third quarter of the year.

   insidermonkey.comOct 4, 2026 04:56 UTCHigh importance
2. ▲ Bullish

   Iovance Biotherapeutics stock received a fair value boost due to demand for Amtagvi.

   finance.yahoo.comOct 3, 2026 21:07 UTC
3. ▲ Bullish

   Iovance stock surged due to strong demand for melanoma drugs.

   barrons.comSep 29, 2026 16:06 UTCHigh importance